These data indicate that miR-27a induces mesenchymal features, promotes tumor metastasis, and CDDP-resistance in NSCLC cells, by directly targeting RKIP (Raf Kinase Inhibitory Protein) [82]. This evidence concerns the gene PEBP1 and non-small cell lung carcinoma.